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ABSTRACT: Protein ﬂexibility is central to enzyme catalysis, yet it remains
challenging both to predict conformational behavior on the basis of analysis of
amino acid sequence and protein structure and to provide the necessary breadth
of experimental support to any such predictions. Here a generic and rapid
procedure for identifying conformational changes during dihydrofolate reductase
(DHFR) catalysis is described. Using DHFR from Escherichia coli (EcDHFR),
selective side-chain 13C labeling of methionine and tryptophan residues is shown
to be suﬃcient to detect the closed-to-occluded conformational transition that follows the chemical step in the catalytic cycle,
with clear chemical shift perturbations found for both methionine methyl and tryptophan indole groups. In contrast, no such
perturbations are seen for the DHFR from the psychrophile Moritella profunda, where the equivalent conformational change is
absent. Like EcDHFR, Salmonella enterica DHFR shows experimental evidence of a large-scale conformational change following
hydride transfer that relies on conservation of a key hydrogen bonding interaction between the M20 and GH loops, directly
comparable to the closed-to-occluded conformational change observed in EcDHFR. For the hyperthermophile Thermotoga
maritima, no chemical shift perturbations were observed, suggesting that no major conformational change occurs during the
catalytic cycle. In spite of their conserved tertiary structures, DHFRs display variations in conformational sampling that occurs
concurrently with catalysis.
Protein motions play important roles in enzyme catalysis,and they are often necessary for progression through the
catalytic cycle. Originally postulated more than half a century
ago in Koshland’s “induced ﬁt” model,1 conformational changes
have only more recently been shown to be widely important for
substrate binding and product release and to provide an
optimal environment for catalysis.2 Indeed, multiple enzyme
families that display conserved motions during catalysis have
been discovered, which indicates evolutionary pressures on
both enzyme tertiary structures and the associated dynamics.3,4
Members of the dihydrofolate reductase (DHFR) class of
enzymes are considered to follow similar catalytic cycles and
represent a classical enzyme model in which conformational
changes occur within the catalytic cycle,5 yet in diﬀerent DHFR
orthologs, variations in conformational dynamics have been
identiﬁed.6−11 Understanding this diversity of protein motions
will in principle help to reveal their importance for the
progression through the catalytic cycle and the inﬂuence of
motions on catalytic proﬁciency.
DHFRs catalyze transfer of the pro-R hydride of reduced
nicotinamide adenine dinucleotide phosphate (NADPH) to
7,8-dihydrofolate (DHF) to form 5,6,7,8-tetrahydrofolate
(THF). THF acts as a one-carbon shuttle in the metabolism
of purines, thymidylate, and certain amino acids and as a result
is critical for cellular proliferation. As DHFR is paramount in
maintaining the intracellular pool of THF, it has been a long-
standing target for both antibacterial and antineoplastic drugs.12
The canonical DHFR catalytic cycle, derived from studies of
Escherichia coli DHFR (EcDHFR), exhibits ﬁve intermediate
complexes13 that adopt two distinct conformations, namely,
closed and occluded (Figures 1 and 2).7 EcDHFR contains
three mobile loops within its structure: the highly mobile M20
loop (residues 9−24 by EcDHFR numbering), the FG loop
(residues 116−132), and the GH loop (residues 142−149).7
The holoenzyme (E:NADPH) ﬁrst binds DHF to form the
Michaelis complex (E:NADPH:DHF). In both these inter-
mediates, a network of hydrogen bonds between residues in the
M20 and FG loops stabilizes a closed conformation,7 in which
the enzyme possesses the optimal electrostatic environment for
hydride transfer.7,14 After product formation, these interactions
are disrupted and new hydrogen bonds are established between
the M20 and GH loops, stabilizing an occluded conformation,
which is conserved in the three remaining intermediates
(E:NADP+:THF, E:THF, and E:THF:NADPH) of the catalytic
cycle. Release of NADP+ and rebinding of NADPH precede the
release of THF from the active site, which at pH 7 is the rate-
limiting step of the reaction.7 Interchange between the closed
and occluded conformations has been shown to modulate the
aﬃnity for the nicotinamide cofactor and to be important for
product release.7,13,15
Variations in the conformational changes seen in EcDHFR
have been identiﬁed in other DHFR homologues. For the
DHFR from the psychrophile Moritella profunda (MpDHFR),
which shares 55% sequence identity with EcDHFR,16 the
catalytic cycle progresses without the enzyme adopting the
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occluded conformation following hydride transfer,10 even
though the tertiary structures of EcDHFR and MpDHFR are
nearly superimposable (Figure 2).7,17 Crucially, hydrogen
bonding between Ser148 and Asn23 is important for stabilizing
the occluded conformation; it is abolished in MpDHFR
because of a proline residue in place of Ser148.10 Nonetheless,
kinetically MpDHFR follows a catalytic cycle similar to that of
EcDHFR, where release of product is the rate-limiting step
under steady state conditions at pH 7.17 The homodimeric
DHFR from the hyperthermophile Thermotoga maritima
(TmDHFR) exhibits a catalytic activity much lower than that
of EcDHFR.6,18,19 Residues corresponding to the FG loop in
TmDHFR form part of the dimer interface, and TmDHFR is
thought to proceed through the catalytic cycle in an open
conformation, although fully conclusive experimental evidence
is still lacking.6,18,19
Phylogenetic analysis indicates that among bacterial DHFRs
there is diversity in whether the hydrogen bond donor and
acceptor necessary to permit formation of the occluded
conformation are present.20 Meanwhile, for mammalian
DHFRs, a proline rich region (PWPP) is inserted into the
M20 loop, resulting in diminished ﬂexibility.11,21,22 This has
been demonstrated to aﬀect the stability of the occluded
conformation, and the N23PP and N23PP/S148A variants of
EcDHFR remain in the closed conformation after the chemical
step and show reduced catalytic activity (diminished kcat), with
dissociation of NADP+ becoming rate-limiting.21 In contrast,
EcDHFR-S148P cannot form an occluded conformation and
displays an increased level of product inhibition, but the rate of
hydride transfer is not signiﬁcantly diﬀerent from that of wild-
type EcDHFR.10 Together, these results indicate that while the
occluded conformation has little inﬂuence on hydride transfer,
it is important for modulating cofactor binding aﬃnities and
minimizing product inhibition.10,21 Bacterial DHFRs that
conserve the Asn23−Ser148 interaction or possess an
equivalent stabilizing interaction should adopt conformations
similar to that of the occluded conformation in EcDHFR.10
Although a wealth of kinetic and structural data is available
for a number of DHFRs,5 there currently exists no rapid and
cost-eﬀective method for assessing enzyme conformational
states and loop dynamics for diverse DHFR orthologs. Notably,
there are crystal structures of DHFRs from >20 organisms,20
but these structures rarely describe the entire catalytic cycle and
are often determined for apoenzymes or solely with the
inhibitors methotrexate and trimethoprim. Moreover, for those
DHFR structures that are anticipated to lack the occluded
conformation, such as those for the enzymes from Bacillius
anthracis8 and Lactobacillus casei,9,25 one can infer diﬀerences
from only the model conformational cycle, because the absence
of structural evidence of an occluded conformation does not
necessarily imply that the conformation is not adopted. Here
we demonstrate that by selective 13C labeling of methionine
and tryptophan side chains only, conformations in solution can
be probed rapidly and highly cost-eﬀectively by nuclear
magnetic resonance (NMR) spectroscopy at diﬀerent stages
of the catalytic cycle for diﬀerent DHFR orthologs. The
reduced spectral complexity compared to those of more
conventional backbone NMR methods aids interpretation and
avoids more cumbersome assignment steps. We show that loop
motions essential for progression through the catalytic cycle in
EcDHFR are not necessary for eﬃcient catalysis in other
orthologs7−9,13,25 and present the ﬁrst clear experimental
evidence in solution that TmDHFR remains in an open
conformation throughout the catalytic cycle. Furthermore, we
show that DHFR from Salmonella enterica (SeDHFR) exhibits
conformational behavior similar to that of EcDHFR, in that it
adopts an additional conformation after the chemical step. This
work conﬁrms the importance of hydrogen bonding
interactions between the M20 and GH loops in stabilizing
alternative occluded-like conformations within the product
complex and demonstrates that EcDHFR is not unique in its
ability to switch between conformations.
■ MATERIALS AND METHODS
Indole (2-13C) was purchased from Cambridge Isotope
Laboratories. NADP+ and NADPH were purchased from
Melford. DHF was produced by sodium dithionite reduction of
folate as described previoulsy.26 All other chemicals, including
L-methionine-(methyl-13C), were from Sigma-Aldrich. DHFRs
were grown in minimal medium and prepared as previously
reported,17 with the exception of the addition of either L-
methionine-(methyl-13C)27 (80 mg L−1) or indole-(2-13C)28
(50 mg L−1) at an OD600 of 0.4. EcDHFR, MpDHFR, and
SeDHFR were puriﬁed via anion exchange chromatography
(Q-Sepharose) followed by size exclusion chromatography.29
For SeDHFR, the procedure was adjusted from that published
for EcDHFR and is outlined in Figure S1. TmDHFR was
puriﬁed as previously described.19 The SeDHFR encoding gene
(Uniprot entry P12833) was purchased from Genscript within
the pET-11b vector. The SeDHFR-S150A variant was prepared
by standard site-directed mutagenesis methods with primers
(Fwd, 5′ GCGGACGATAAGAACGCGTATGCGTGCGAG-
TTTG 3′; Rev, 5′ CAAACTCGCACGCATACGCGTTCTT-
ATCGTCCGC 3′) that were purchased from Sigma-Aldrich
and expressed and puriﬁed as for wild-type SeDHFR.
All NMR experiments were performed on a Bruker
AVANCE III 600 MHz (1H) spectrometer equipped with a
QCI-P cryoprobe and ﬁnal enzyme concentrations of
approximately 250 μM. EcDHFR, MpDHFR, and SeDHFR
were prepared in 50 mM potassium phosphate buﬀer (pH 7.0)
Figure 1. Catalytic cycle of EcDHFR under steady state conditions at
pH 7. The major protein conformations adopted by the complexes in
the catalytic cycle are indicated: open/disordered (green), closed
(red), and occluded (blue).7,23,24
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containing 1 mM NaCl and 10 mM β-mercaptoethanol.
TmDHFR was prepared in 50 mM Tris buﬀer (pH 7.0)
containing 1 mM NaCl and 10 mM β-mercaptoethanol. Ligand
stocks were pre-prepared at a concentration of 100 mM and pH
7, using extinction coeﬃcients of 6200 cm−1 M−1 at 339 nm,30
17800 cm−1 M−1 at 260 nm,31 and 28000 cm−1 M−1 at 282
nm32 for NADPH, NADP+, and folate/DHF, respectively. A
10-fold excess of ligands was used in each NMR experiment
and the sample adjusted to pH 7.0 before measurement of the
spectra, ensuring saturation (Table S1). To form the
E:NADP+:THF complex, NADPH and DHF were incubated
with the enzyme for 20 min at 37 °C, with reaction completion
and the absence of oxidation products conﬁrmed by 1H NMR.
D2O (10%) was added to all NMR samples. Spectra for
MpDHFR, EcDHFR, SeDHFR, and TmDHFR were recorded
at 7, 25, 25, and 40 °C, respectively, to maintain sample
integrity and to be close to physiological conditions for each
enzyme. Spectra were processed with NMRPipe33 and analyzed
using CcpNmr Analysis 2.4.1.34
With the exception of Met94, all methionine methyl
resonances of MpDHFR had been published previously.35
The assignment of the Met94 resonances was conﬁrmed, and
tryptophan indole-δ1 resonances were assigned by re-evaluation
of the three-dimensional (3D) 13C- and 15N-edited NOESY
spectra acquired previously.35 Each tryptophan indole NH
resonance showed an intense NOESY crosspeak to a unique
indole-δ1
1H resonance observed here, readily allowing
assignment. For EcDHFR, methionine methyl resonances and
tryptophan indole-δ1 resonances for EcDHFR were similarly
assigned using 3D 13C-edited NOESY, CCH-TOCSY, and
HCCH-TOCSY spectra acquired on a Varian INOVA 800
MHz (1H) spectrometer equipped with a cryogenically cooled
HCN probe, using the 3D 15N-edited NOESY spectrum
acquired previously,36 and by reference to published data.37
The equation Δδ = [1/2(δH2 + δC2/4)]1/2 was used to obtain
weighted average chemical shift perturbations.38
■ RESULTS AND DISCUSSION
To investigate the distribution of protein conformations during
the catalytic cycle of diﬀerent DHFR orthologs, EcDHFR and
MpDHFR were ﬁrst probed as models to identify whether
systematical labeling of the proteins with [methyl-13C]-
methionine27 and [indole-δ1-
13C]tryptophan28 could identify
catalytic cycles that include or omit the occluded conformation.
TmDHFR and SeDHFR were investigated to elucidate their
conformational behavior, which had not been explored
previously. Methionine comprises 3.1% of amino acid residues
in MpDHFR and EcDHFR, 2.4% in TmDHFR, and 1.8% in
SeDHFR, while tryptophan makes up 3.1% of the tryptophan
amino acid residues in EcDHFR, 1.9% in MpDHFR and
SeDHFR, and 0.6% in TmDHFR. This density ensured that a
good description of protein conformational space was achieved
without signiﬁcant spectral crowding (Figure 2 and Figure
S2).6,7,17,18 In addition, a number of methionine and
tryptophan residues are conserved in structurally signiﬁcant
positions.6,7,16 Most notably, Trp22 in the M20 loop (Figure
S2) is found in a wide range of DHFR orthologs and has been
shown to be important for EcDHFR catalysis.39 Similarly,
Met42 is strongly conserved. In total, four of the ﬁve
methionine residues in EcDHFR are conserved in MpDHFR
(Met1, Met20, Met42, and Met92), and three of the ﬁve are
conserved in SeDHFR (Met1, Met42, and Met92), although
only Met44 is conserved in TmDHFR (Figure S2). The two
remaining methionines in TmDHFR are located within the
dimer interface. In addition to Trp22, EcDHFR, MpDHFR,
and SeDHFR possess a Trp133 equivalent, although other
tryptophan residues are well-dispersed throughout the protein
structure. Met1 in TmDHFR is mostly removed during
expression by an aminopeptidase present in E. coli (Figure
S3).40
1H−13C HSQC spectra of EcDHFR labeled with
[methyl-13C]methionine or [indole-δ1-
13C]tryptophan (Figure
3A,B and Tables S2 and S3) exhibit ﬁve distinct cross-peaks
corresponding to the ﬁve methionine and ﬁve tryptophan
residues in the presence of ligands. The quality of the spectrum
for [methyl-13C]methionine-labeled apoenzyme was lower, with
multiple minor cross-peaks observed for some residues (Figure
S5). This is characteristic of spectra of apo-EcDHFR and apo-
MpDHFR where the enzyme is in slow exchange between
multiple conformational states.36,41 Addition of ligands
(NADP+ and folate to model the Michaelis complex or
NADP+ and THF to form the product ternary complex)
resulted in improved spectral quality, reduction in the number
of cross-peaks, and increased resolution.36 Complex formation
also led to signiﬁcant changes in chemical shift, indicative of the
enzyme undergoing a transition to a new conformation.
Dramatic changes in chemical shift were also observed between
the E:NADP+:folate and E:NADP+:THF complexes, as the
enzyme progressed to an occluded conformation after the
chemical step. The largest chemical shift perturbations were
exhibited by Met20 and Trp22, located in the highly ﬂexible
M20 loop; Met16, Met92, and Trp133 also showed notable
changes.
Figure 2. Cartoon representations of EcDHFR (cyan, PDB entry
1RX27), TmDHFR (green, PDB entry 1D1G6), and MpDHFR (red,
PDB entry 3IA529). The “M20” loop in the occluded (black) and
closed (yellow) conformations is highlighted as well as positions of
methionine (blue) and tryptophan (purple).
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As with the spectrum of [methyl-13C]methionine-labeled apo-
EcDHFR, the 1H−13C HSQC spectra of apo-MpDHFR labeled
with [methyl-13C]methionine or [indole-δ1-
13C]tryptophan
exhibited clear evidence of conformational heterogeneity
(Figure S5). Again, addition of ligands led to an increase in
spectral quality, indicative of the enzyme adopting one major
conformation. 1H−13C HSQC spectra of the two complexes
showed the expected ﬁve methionine and three tryptophan
cross-peaks (Figure 3C,D). No signiﬁcant change in chemical
shift was observed between the Michaelis and product
complexes for methionine or tryptophan residues (Tables S4
and S5). Notably, small changes in proton chemical shifts for
Met21 and Trp23 were observed, but as these residues are
directly adjacent to the site of chemistry, these most likely
occur because of the diﬀerences in ligands, highlighting how it
is important to diﬀerentiate between small changes that
describe the changes at the site of chemistry and more
Figure 3. 1H−13C HSQC spectra of 13C-labeled DHFR complexes, E:NADP+:folate (closed conformation in EcDHFR) (blue) and E:NADP+:THF
(occluded conformation in EcDHFR) (red): (A) [methyl-13C]methionine-labeled EcDHFR, (B) [δ1-
13C]tryptophan-labeled EcDHFR, (C)
[methyl-13C]methionine-labeled MpDHFR, (D) [δ1-
13C]tryptophan-labeled MpDHFR, (E) [methyl-13C]methionine-labeled TmDHFR, (F)
[δ1-
13C]tryptophan-labeled TmDHFR, (G) [methyl-13C]methionine-labeled SeDHFR, (H) [δ1-
13C]tryptophan-labeled SeDHFR, (I) [methyl-13C]-
methionine-labeled SeDHFR-S150A, and (J) [δ1-
13C]tryptophan-labeled SeDHFR-S150A.
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widespread chemical shift deviations, indicative of protein
conformational changes as observed for EcDHFR.
The extensive diﬀerences in chemical shifts seen in the
EcDHFR:NADP+:folate and EcDHFR:NADP+:THF com-
plexes, as had previously been observed for [15N]alanine-
labeled EcDHFR,42 provide clear evidence that methionine and
tryptophan labeling is suﬃcient to observe the closed-to-
occluded conformational change in EcDHFR. As expected,
residues in the ﬂexible M20 loop (Met16, Met20, and Trp22)
all show large changes. Met16 in the apoenzyme and Michaelis
complex appears to be solvent-exposed. However, in the
product complex, the residue is located directly within the
active site,7 drastically changing the immediate molecular
environment of the 13C methyl group. Again, Met20 in the
Michaelis complex points toward the FG loop, whereas in the
product complex, it is more solvent-exposed, thus accounting
for the observed downﬁeld shift. Importantly, in EcDHFR,
chemical shift changes are widely observed for all methionine
and most tryptophan resonances, allowing binding eﬀects of
diﬀerent ligands and deviations in protein conformation to be
diﬀerentiated. No such widespread and signiﬁcant changes in
c h em i c a l s h i f t w e r e o b s e r v e d b e t w e e n t h e
MpDHFR:NADP+:folate and MpDHFR:NADP+:THF com-
plexes, conﬁrming earlier work that suggested that MpDHFR
does not adopt an occluded conformation after hydride
transfer.10 The results gained from EcDHFR and MpDHFR
conﬁrm that selective side-chain labeling can be used to identify
whether an occluded-like conformation is adopted by a speciﬁc
DHFR.
It has so far been challenging to investigate TmDHFR by
conventional NMR methods because of poor tumbling in
solution and fast T2 relaxation as a consequence of its dimeric
nature with a total molecular mass of 38k and its elongated
shape.18 Perdeuteration of TmDHFR to improve relaxation
issues proved to be ineﬀective as the high thermal stability of
TmDHFR prevented complete proton back-exchange of
backbone amide groups in non-solvent-exposed regions (Figure
S4). Consequently, three-dimensional NMR spectra of
TmDHFR are of limited quality, and no triple-resonance
assignment data for TmDHFR have been published. However,
TmDHFR contains only three methionines and one
tryptophan.18 Because these side chains display superior
relaxation properties, selective side-chain labeling can be used
to explore the conformational dynamics of TmDHFR. 1H−13C
HSQC spectra of TmDHFR exhibit four distinct methionine
cross-peaks and one tryptophan cross-peak (Figure 3E,F). Met1
could be assigned as the intensity of this resonance was
considerably lower than the others, as expected for a residue
present in only ∼10% of the protein molecules because of
aminopeptidase activity in E. coli (Figure S3). No signiﬁcant
changes in [methyl-13C]methionine chemical shifts were
observed between the apoenzyme and either complex (Tables
S6 and S7). Trp23 displays a proton shift diﬀerence of 0.07
ppm between the Michaelis and product complexes, similar to
that observed for MpDHFR. This diﬀerence is most likely due
to diﬀerent ligands, which are directly proximal to Trp23.
These results suggest that TmDHFR adopts only a single major
conformation in solution.
The occluded conformation has so far only been observed in
EcDHFR, although some evidence of conformational ﬂexibility
following the chemical step has been reported for bacterial
DHFRs.11 We therefore tested our proposal that DHFR
homologues that can form a hydrogen bond similar to the
crucial Ser148−Asn23 interaction in EcDHFR will adopt a
conformation similar to the occluded conformation found in
EcDHFR. SeDHFR contains residues His24 and Ser150 in the
equivalent positions (Figure S2), and the replacement of
asparagine by histidine is not likely to have a negative eﬀect
because the hydrogen bonds are formed to the backbone amide
and carbonyl of Asn23. SeDHFR should therefore adopt an
occluded-like conformation following the chemical step. No
NMR assignments or structural information currently exists for
SeDHFR, although tentative assignment of methionine residues
could be performed via sequence analysis, indicating that
conserved residues are likely to reside in electronic environ-
ments similar to those in EcDHFR and MpDHFR. Like
EcDHFR and MpDHFR, the quality of methyl-13C spectra of
the methionine-labeled SeDHFR apoenzyme was low as a
consequence of conformational heterogeneity (Figure S5).
SeDHFR exhibits three well-deﬁned cross-peaks when in the
E:NADP+:folate complex. However, unlike EcDHFR, SeDHFR
shows two distinct species in the E:NADP+:THF complex;
both species seem to be equally populated (Figure 3G,H). Half
of the cross-peaks present in the product complex overlap with
those present in the Michaelis complex, indicating that in the
product complex SeDHFR is characterized by an equilibrium
between the Michaelis conformation and a second conforma-
tional state (Tables S8 and S9). It is worth noting that changing
Ser148 in EcDHFR leads to a destabilization of the occluded
conformation.21 To conﬁrm whether the two observed species
in SeDHFR related to similar conformational behavior,
SeDHFR-S150A was prepared. In the product complex, two
species were present in this variant, but the relative population
of the two states was drastically shifted to favor the Michaelis
complex (Figure 3I,J and Tables S10 and S11). This reinforced
the idea that the chemical shift perturbations observed in
Met94 and Met42 are likely to be caused by a conformational
change resembling that found in EcDHFR and again conﬁrmed
the signiﬁcance of the hydrogen bond interaction between the
M20 and GH loops in its formation. No signiﬁcant chemical
shift perturbations were observed in the [indole-δ1-
13C]-
tryptophan-labeled SeDHFR, which in this instance proved
not to be diagnostic of conformational change.
SeDHFR, unlike EcDHFR and MpDHFR, lacks methionine
residues within the M20 loop, which directly participates in the
closed-to-occluded conformational change. To provide further
evidence that the second conformation present in the product
complex of SeDHFR resembles the occluded conformation
observed for EcDHFR, 1H−15N HSQC spectra of both the
Michaelis and product complexes were recorded (Figures S6
and S7). As observed through the [methyl-13C]methionine
resonances, widespread chemical shift diﬀerences are found
between the complexes, again justifying that simple side-chain
labeling is suﬃcient to identify conformational change within
DHFRs, even when the probes are not located directly within
the site of conformational change. This suggested that SeDHFR
does indeed form an occluded-like conformation.
In general, we found [methyl-13C]methionine chemical shifts
more diagnostic of DHFR conformational changes than those
of [indole-δ1-
13C]tryptophan. In all four DHFRs, Trp22 forms
a hydrogen bond to bound folates. It would therefore be
expected to show a diﬀerence in chemical shift between the
apoenzyme and the two complexes. In MpDHFR and
TmDHFR, Trp23 does indeed display small proton chemical
shifts for each separate complex, while in contrast, no
signiﬁcant diﬀerences are observed for SeDHFR. A large
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deviation is found for the Michaelis complex of EcDHFR, but
apoenzyme and product complexes are similar. Taken together,
this illustrates how ligand binding eﬀects dominate for this
residue because of its location adjacent to the site of chemistry,
obscuring any chemical shift perturbations in response to
protein conformational changes. Similarly, for the spectra of
apo-EcDHFR, MpDHFR, and SeDHFR, the tryptophan data
show no evidence of the conformational heterogeneity
obviously present upon observation of [methyl-13C]methionine
spectra and previously reported.28,43 Conformational changes
can nonetheless be followed through [indole-δ1-
13C]tryptophan
labeling, because there is clear evidence for the closed-to-
occluded transition in EcDHFR, which may simply be more
evident for EcDHFR than for SeDHFR because of the larger
number of [indole-δ1-
13C]tryptophans present within its
sequence.
Importantly, by combination of the [indole-δ1-
13C]-
tryptophan labeling with [methyl-13C]methionine labeling,
which could in principle have been performed in a single
protein, clear evidence of large-scale protein conformational
changes was found for EcDHFR and SeDHFR. In EcDHFR,
the ability to switch to an occluded conformation is essential for
progression through the catalytic cycle, but this had not
previously been observed in other DHFRs.10,11 Ser148 in
EcDHFR, which forms two hydrogen bonds to the M20 loop, is
replaced with proline in MpDHFR.10 Consequently, M20 loop
motions appear not to play a signiﬁcant role in MpDHFR
catalysis, and it was known that MpDHFR remains in a closed
conformation throughout the catalytic cycle.10,44 Switching
from the closed to the occluded conformation immediately
follows hydride transfer in EcDHFR, before release of NADP+
from the product ternary complex.45 Switching to the occluded
conformation in EcDHFR lowers the binding aﬃnity of
NADP+, mitigates possible product inhibition eﬀects, and
allows eﬃcient progress through the catalytic cycle.10,46
However, similar single-turnover rate constants for EcDHFR-
and MpDHFR-catalyzed hydride transfer at pH 7 show that the
ability to form the occluded conformation does not have a
major eﬀect on the chemical step. Hydride transfer in the
occluded conformation is not possible because of the distance
between the reactants.10,36
Despite the lack of assignment data for both Tm- and
SeDHFR, important conclusions can be drawn from the data
presented here. Side-chain labeling of methionine and
tryptophan yields simple and intuitively useful data. Previous
reports that TmDHFR remains in a ﬁxed open conformation
during catalysis were based upon two X-ray single-crystal
structures, and neither of them eﬀectively modeled the
Michaelis or product complex.18 Hence, here the ﬁrst direct
evidence that TmDHFR remains ﬁxed in an open conformation
throughout the catalytic cycle is reported. Any further emphasis
is however limited for TmDHFR because of the diﬀerent
distribution of methionine residues to Ec- and MpDHFR and
highlights how the distribution and conservation of labels can
be potentially limiting when establishing conformational
changes and comparing orthologs.
The ease of labeling meant that the conformational behavior
of SeDHFR, for which no structural data exist, could be
analyzed rapidly, and predictions based upon primary sequence
analysis were veriﬁed. SeDHFR exists in multiple solution
forms, and their assignment could be based on similarity to
other DHFRs. Like EcDHFR, SeDHFR showed two con-
formations in the product complex, but the relative stability of
two conformations was evidently diﬀerent. The occluded
conformation dominates in the product complex of EcDHFR,
while in SeDHFR, the Michaelis conformation is still present at
an approximately equimolar concentration. This diﬀerence may
inﬂuence the kinetics of product release.
Principally selective side-chain 13C labeling provides a rapid
and cost-eﬀective approach for surveying protein conformations
during catalysis for multiple proteins, allowing more traditional
and detailed analysis to be adjudged worthwhile. The cost of
production of proteins labeled with [methyl-13C]methionine
(£11 per liter of culture) and [indole-δ1-
13C]tryptophan (£96
per liter of culture) is considerably lower than that of triply (2H,
13C, 15N, £622 per liter of culture) or doubly (13C, 15N, £262
per liter of culture) labeled proteins required for full NMR
assignments (when accounting for 4 g L−1 [U-2H,13C]- or
[U-1H,13C]glucose, respectively). Selective labeling also pro-
vides greatly simpliﬁed spectra, exhibiting only a fraction of the
number of cross-peaks seen for fully labeled proteins, and the
data can be acquired over much narrower spectral windows
(10−14 ppm in 13C rather than ∼70 ppm for a full aliphatic
1H−13C HSQC spectrum). In addition, 13CH3 groups (as in
[methyl-13C]methionine) typically show high sensitivity in
NMR experiments, because of the three equivalent protons,43
and aliphatic 13C shifts are most sensitive to conformational
changes.38 For DHFR, selective side-chain 13C labeling is
clearly suﬃcient to gain insight into large-scale protein motions
that are important for progression through the catalytic cycle
and expands upon previous work that demonstrated for
EcDHFR the eﬀectiveness of side-chain labeling methods in
measuring picosecond to nanosecond time-scale protein
dynamics.47
In conclusion, we have demonstrated here the utility of
selective side-chain labeling to rapidly probe conformational
behavior during DHFR catalysis. EcDHFR is known to undergo
large-scale conformational changes along the catalytic cycle and
shows clear chemical shift perturbations of its methionine
methyl and tryptophan indole groups following the chemical
step. MpDHFR, on the other hand, an enzyme known to
maintain a single major conformation during catalysis, does not
display such perturbations. Thermostable, homodimeric
TmDHFR does not show any signiﬁcant chemical shift
perturbations following the chemical step, corroborating
crystallographic evidence and providing the ﬁrst direct evidence
that this enzyme also adopts a single major conformation in
solution. Conformational sampling is, however, not unique to
EcDHFR, and DHFR from S. enterica exhibits similar
conformational behavior, most likely adopting an occluded-
like conformation. Clearly, amino acid sequence analysis allows
the prediction of large-scale protein conformational behavior in
DHFRs, and spectra obtained with site selectively labeled
proteins may be readily interpreted even in the absence of
resonance assignments. However, the scope of selective side-
chain 13C labeling is not limited to an analysis of structural
events during DHFR catalysis and can be used to track
conformational changes in a wide range of proteins.
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